Ann Hynes
Stock Analyst at Mizuho
(2.36)
# 1054
Out of 5,218 analysts
258
Total ratings
65.19%
Success rate
18.66%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Pediatrix Medical Gr... | Maintains: Neutral | 13 15 | 14.06 | 6.69% | 11 | Nov 19, 2024 | |
Elevance Health | Maintains: Outperform | 585 505 | 380.91 | 32.58% | 3 | Nov 5, 2024 | |
Cardinal Health | Maintains: Neutral | 110 120 | 118.15 | 1.57% | 8 | Nov 4, 2024 | |
BrightSpring Health | Maintains: Outperform | 17 20 | 18.56 | 7.76% | 1 | Nov 4, 2024 | |
Quest Diagnostics | Maintains: Outperform | 160 174 | 155.09 | 12.19% | 12 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 73 66 | 49.39 | 33.63% | 9 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 28 | 20.5 | 36.59% | 1 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 20 | 16.71 | 19.69% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 235 | 190.3 | 23.49% | 1 | Jun 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 27 | 19.78 | 36.5% | 1 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 435 | 345.86 | 25.77% | 1 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 84 70 | 40.66 | 72.16% | 9 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Strong Buy | 118 130 | 136.7 | -4.9% | 14 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 93 95 | 98.2 | -3.26% | 8 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 346 346 | 208.16 | 66.22% | 13 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 370 385 | 281.79 | 36.63% | 10 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 175 200 | 187.25 | 6.81% | 15 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 242 268 | 2.27 | 11706.17% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 450 505 | 576.49 | -12.4% | 17 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 550 400 | 273.6 | 46.2% | 7 | Jan 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 257 230 | 232.46 | -1.06% | 15 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 325 275 | 314.03 | -12.43% | 19 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 31 25 | 10.42 | 139.92% | 8 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 250 229 | 199.24 | 14.94% | 10 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 48 50 | 20.36 | 145.58% | 2 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 600 549 | 521.04 | 5.37% | 16 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 80 76 | 59.46 | 27.82% | 7 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 174 192 | n/a | n/a | 10 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 38 43 | n/a | n/a | 9 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 345 366 | 303.12 | 20.74% | 6 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 450 510 | n/a | n/a | 5 | Dec 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 32 | n/a | n/a | 1 | Mar 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 82 0 | n/a | n/a | 2 | Jan 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 90 0 | n/a | n/a | 2 | Nov 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 57 | 1.31 | 4251.15% | 1 | Sep 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Jul 20, 2017 |